Xbrane Biopharma AB (publ) (STO:XBRANE)

Xbrane Biopharma AB Revenue

Xbrane Biopharma AB had revenue of 10.12M SEK in the quarter ending September 30, 2025, a decrease of -37.49%. This brings the company's revenue in the last twelve months to 259.70M, up 74.08% year-over-year. In the year 2024, Xbrane Biopharma AB had annual revenue of 198.72M, down -16.76%.

• Revenue (ttm): 259.70M
• Revenue Growth: +74.08%
• P/S Ratio: 0.82
• Revenue / Employee: 9.99M
• Employees: 26
• Market Cap: 212.73M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	198.72M	-40.01M	-16.76%
Dec 31, 2023	238.73M	181.11M	314.33%
Dec 31, 2022	57.62M	46.91M	438.03%
Dec 31, 2021	10.71M	-	-
Dec 31, 2020	-	-	-